This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garber, K. Lymphoma market turf war imminent, pending Bexxar approval. Nat Biotechnol 21, 115–116 (2003). https://doi.org/10.1038/nbt0203-115
Issue Date:
DOI: https://doi.org/10.1038/nbt0203-115
This article is cited by
-
US biosecurity advisory board faces delicate balancing act
Nature Biotechnology (2005)